Xiangyu Wang
127 Dongming Road
Zhengzhou, 450008, China
Zhengzhou, 450008, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Retraction Note: A novel chalcone derivative S17 induces apoptosis through ROS dependent DR5 up-regulation in gastric cancer cells.
Journal: Scientific reports
Published: January 19, 2026
Chronic Stress-Induced m7G Cap Modification of ADRB2 Dysregulates the Pentose Phosphate Pathway to Promote Esophageal Squamous Cell Carcinoma Progression.
Journal: Cancer research
Published: December 17, 2025
Chronic stress-induced cholesterol metabolism abnormalities promote ESCC tumorigenesis and predict neoadjuvant therapy response.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 27, 2025
INCENP and CDCA8 predict neoadjuvant chemotherapy response and outcomes in esophageal squamous cell carcinoma.
Journal: Nature communications
Published: August 06, 2024
Minimal residual disease detection in lymphoma: methods, procedures and clinical significance.
Journal: Frontiers in immunology
Published: May 09, 2024
Hippocalcin-like 1 is a key regulator of LDHA activation that promotes the growth of non-small cell lung carcinoma.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: January 17, 2022
Anwulignan is a novel JAK1 inhibitor that suppresses non-small cell lung cancer growth.
Journal: Journal of cellular and molecular medicine
Published: October 28, 2020
Long non‑coding RNA NR2F1‑AS1 facilitates the osteosarcoma cell malignant phenotype via the miR‑485‑5p/miR‑218‑5p/BIRC5 axis.
Journal: Oncology reports
Published: March 06, 2020
SP600125 enhances C-2-induced cell death by the switch from autophagy to apoptosis in bladder cancer cells.
Journal: Journal of experimental & clinical cancer research : CR
Published: August 19, 2019
Gossypin inhibits gastric cancer growth by direct targeting of AURKA and RSK2.
Journal: Phytotherapy research : PTR
Published: August 23, 2018
Purpurogallin is a novel mitogen-activated protein kinase kinase 1/2 inhibitor that suppresses esophageal squamous cell carcinoma growth in vitro and in vivo.
Journal: Molecular carcinogenesis
Published: August 21, 2018
Last Updated: 09/26/2026